Abstract
Endoprostheses are now an established technique to reconstruct defects following bone tumour resection. The long-term durability of the reconstruction is excellent, with limb salvage being maintained in the long term in 91% of patients at 20 years from surgery. The main reasons for secondary amputation were locally recurrent disease and deep periprosthetic infection. Infection remains one of the biggest threats to early failure of reconstructions with endoprostheses. Most series of reconstructions show a periprosthetic infection rate of approximately 10%. Infection most frequently occurs within 12 months from the last surgical procedure; however, the risk of infection is life-long. The commonest pathogenic organism is coagulase-negative Staphylococcus. The most effective treatment for deep infection is two-stage revision, with local treatments having little chance of curing deep infection. Research is on-going into surface treatments with silver and other materials to help to reduce the infection rates.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Jeys LM, Grimer RJ, Carter SR, Tillman RM (2003) Risk of amputation following limb salvage surgery with Endoprosthetic replacement, in a consecutive series of 1261 patients. Int Orthop 27:160–163
Sim IW, Tse LF, Ek ET, Powell GJ, Choong PF (2007) Salvaging the limb salvage: management of complications following endoprosthetic reconstruction for tumours around the knee. Eur J Surg Oncol 2007 33:796–802
Sharma S, Turcotte RE, Isler MH, Wong C (2006) Cemented rotating hinge endoprosthesis for limb salvage of distal femur tumors. Clin Orthop Relat Res 450:28–32
Ahlmann ER, Menendez LR, Kermani C, Gotha H (2006) Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg 88:790–795
Futani H, Minamizaki T, Nishimoto Y, Abe S, Yabe H, Ueda T (2006) Long-term follow-up after limb salvage in skeletally immature children with a primary malignant tumor of the distal end of the femur. J Bone Joint Surg Am 88:595–603
Brigman BE, Hornicek FJ, Gebhardt MC, Mankin HJ (2004) Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res 421:232–239
Pickering SAW (2003) Electromagnetic augmentation of antibiotic efficacy in infection of orthopaedic implants. J Bone Joint Surg Br 85:588–593
Gristina AG, Costerton JW (1984) Bacterial adherence and the glycocalyx and their role in musculoskeletal infection. Orthop Clin North Am 15:517–535
Nickel JC, Ruseska I, Wright JB, Costerton JW (1985) Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 27:619–624
Gilbert P, Allison DG (1999) Biofilms and their resistance towards antimicrobial agents. In: Newman HN, Wilson M (eds) Dental plaque revisited: oral biofilms in nature and disease. Bioline Publications, Cardiff, pp 125–143
Greidanus N V, Masri BA, Garbuz DS, Wilson SD, McAlinden MG, Xu M, Duncan CP (2007) Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty. A prospective evaluation. J Bone Joint Surg Am 89:1409–1416
Jeys LM, Grimer RJ, Carter SR, Tillman RM (2005) Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am 87:842–849
Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, Di Cesare PE (2006) Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am 88:1231–1237
Tsukayama DT, Estrada R, Gustilo RB (1996) Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996 78:512–523
Reference deleted in proof
Raut V V, Siney PD, Wroblewski BM (1995) One-stage revision of total hip arthroplasty for deep infection. Long-term follow up. Clin Orthop Relat Res 321:202–207
Callaghan JJ, Katz R P, Johnston RC (1999) One-stage revision surgery of the infected hip. A minimum 10-year followup study. Clin Orthop Relat Res 369:139–143
Colyer RA, Capello WN (1994) Surgical treatment of the infected hip implant. Two-stage reimplantation with a one-month interval. Clin Orthop Relat Res 298:75–79
Younger AS, Duncan C P, Masri BA, McGraw RW (1997) The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty 12:615–623
Reference deleted in proof
Flint MN, Griffin AM, Bell RS, Ferguson PC, Wunder JS (2006) Aseptic loosening is uncommon with uncemented proximal tibia tumor prostheses. Clin Orthop Relat Res 450:52–59
Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 450:164–171
Chen CM, Disa JJ, Lee HY, Mehrara BJ, Hu QY, Nathan S, Boland P, Healey J, Cordeiro PG (2007) Reconstruction of extremity long bone defects after sarcoma resection with vascularized fibula flaps: a 10-year review. Plast Reconstr Surg 119:915–924
Muscolo DL, Ayerza MA, Aponte-Tinao LA, Ranalletta M (2006) Use of distal femoral osteoarticular allografts in limb salvage surgery. Surgical technique. J Bone Joint Surg Am 88[Suppl 12]:305–321
Lascelles BD, Dernell WS, Correa MT, Lafferty M, Devitt CM, Kuntz CA, Straw RC, Withrow SJ (2005) Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol 12:1073–1083
Thrall DE, Withrow SJ, Powers BE, Straw RC, Page RL, Heidner GL, Richardson DC, Bissonnette K W, Betts CW, DeYoung DJ (1990) Radiotherapy prior to cortical allograft limb sparing in dogs with osteosarcoma: a dose response assay. Int J Radiat Oncol Biol Phys 18:1351–1357
Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A (2007) Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol 14: 2887–2895
Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M, Gunsel A, Kemper FH, Winkelmann W, Von Eiff C (2004) Silver-coated megaendoprostheses in a rabbit model—an analysis of the infection rate and toxicological side effects. Biomaterials 25:5547–5556
Hardes J, Ahrens H, Gebert C, Streitbuerger A, Buerger H, Erren M, Gunsel A, Wedemeyer C, Saxler G, Winkelmann W, Gosheger G (2007) Lack of toxicological side-effects in silvercoated megaprostheses in humans. Biomaterials 28:2869–2875
Munukka E, Leppäranta O, Korkeamäki M, Vaahtio M, Peltola T, Zhang D, Hupa L, Ylänen H, Salonen JI, Viljanen MK, Eerola E (2007) Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med [Epub ahead of print]
Lawson MC, Bowman CN, Anseth KS (2007) Vancomycin derivative photopolymerized to titanium kills S. epidermidis. Clin Orthop Relat Res 461:96–105
Price JS, Tencer AF, Arm DM, Bohach GA (1996) Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res 30:281–286
Moussa F W, Gainor BJ, Anglen JO, Christensen G, Simpson WA (1996) Disinfecting agents for removing adherent bacteria from orthopaedic hardware. Clin Orthop Relat Res 329:255–262
Day RE, Megson S, Wood D (2005) Iontophoresis as a means of delivering antibiotics into allograft bone. J Bone Joint Surg Br 87:1568–1574
Michalak KA, Khoo P P, Yates PJ, Day RE, Wood DJ (2006) Iontophoresed segmental allografts in revision arthroplasty for infection. J Bone Joint Surg Br 88:1430–1437
Buttaro M, Comba F, Piccaluga F (2007) Vancomycin-supplemented cancellous bone allografts in hip revision surgery. Clin Orthop Relat Res 461:74–80
Al-Maiyah M, Hill D, Bajwa A, Slater S, Patil P, Port A, Gregg PJ (2005) Bacterial contaminants and antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg Br 87:1256–1258
Periti P, Mini E, Mosconi G (1998) Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin. J Antimicrob Chemother 41: 329–340
Nehrer S, Thalhammer F, Schwameis E, Breyer S, Kotz R (1998) Teicoplanin in the prevention of infection in total hip replacement. Arch Orthop Trauma Surg 118:32–36
Periti P, Stringa G, Mini E (1999) Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery. Eur J Clin Microbiol Infect Dis 18:113–119
de Lalla F (2001) Antibiotic prophylaxis in orthopedic prosthetic surgery. J Chemother 1:48–53
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jeys, L., Grimer, R. (2009). The Long-Term Risks of Infection and Amputation with Limb Salvage Surgery Using Endoprostheses. In: Tunn, PU. (eds) Treatment of Bone and Soft Tissue Sarcomas. Recent Results in Cancer Research, vol 179. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77960-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-77960-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77959-9
Online ISBN: 978-3-540-77960-5
eBook Packages: MedicineMedicine (R0)